Hong Kong · SFC › Firms
CStone Pharmaceuticals
基石藥業
Hong Kong listed company Stock code 2616
Board members with SFC licence histories
Back to top ↑| Name | Position | From | To |
|---|---|---|---|
| Hitchner III, Kenneth Walton | Non-Executive Director | 10 Dec 2021 | present (as of 24 Dec 2025) |
| Cao, Yanling曹彥凌 | Non-Executive Director | 15 May 2019 | 18 Jan 2023 |
| Tong, Xiaomeng童小幪 | Non-Executive Director | 28 Feb 2018 | 15 May 2019 |
Listings
Back to top ↑| Market | Stock code | First traded | Delisted |
|---|---|---|---|
| SEHK Main Board | 2616 | 26 Feb 2019 | — |
Former names
Back to top ↑- CStone Pharmaceuticals · until 18 Feb 2019
Sources: Webb-site archive (Enigma database). Status checked with: SFC monthly report; SFC register snapshot; Webb-site archive (Enigma database). As of: 31 Oct 2026.
History comes from the Webb-site archive and is updated from public data. It may lag the official register, so check the SFC for the current position. Report an error.